JPMorgan Chase & Co. Reaffirms Neutral Rating for Bodycote (LON:BOY)

Key Points

• Bodycote has received a "neutral" rating from JPMorgan Chase & Co., which reflects a cautious outlook on the stock's performance.
• Berenberg Bank and Deutsche Bank both issued a "buy" rating, with target prices set at GBX 800 ($10.62) and GBX 700 ($9.29) respectively.
• The company's recent earnings report showed an earnings per share of GBX 21.30 ($0.28) and a current market cap of £1.13 billion.

Bodycote (LON:BOY - Get Free Report)'s stock had its "neutral" rating restated by equities research analysts at JPMorgan Chase & Co. in a research note issued on Monday, Marketbeat Ratings reports.

A number of other brokerages have also recently weighed in on BOY. Berenberg Bank reissued a "buy" rating and set a GBX 800 ($10.76) price objective on shares of Bodycote in a report on Wednesday, July 30th. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and issued a GBX 700 ($9.41) price target on shares of Bodycote in a research note on Thursday, July 31st. Finally, Royal Bank Of Canada lifted their price target on Bodycote from GBX 650 ($8.74) to GBX 775 ($10.42) and gave the stock an "outperform" rating in a research note on Thursday, July 31st.

Bodycote Price Performance

Shares of LON BOY traded down GBX 7.50 ($0.10) during trading hours on Monday, reaching GBX 628.50 ($8.45). 136,588 shares of the stock traded hands, compared to its average volume of 494,493. The company has a market capitalization of £1.13 billion, a P/E ratio of 18.91, a price-to-earnings-growth ratio of 1.44 and a beta of 1.18. The company has a quick ratio of 0.74, a current ratio of 0.81 and a debt-to-equity ratio of 20.84. Bodycote has a 52-week low of GBX 449.40 ($6.04) and a 52-week high of GBX 701 ($9.43). The company's 50-day simple moving average is GBX 588.79 and its two-hundred day simple moving average is GBX 577.50.

Bodycote (LON:BOY - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported GBX 21.30 ($0.29) earnings per share for the quarter. Bodycote had a return on equity of 8.14% and a net margin of 8.01%. Equities research analysts forecast that Bodycote will post 54.0540541 EPS for the current year.

Bodycote Company Profile

The leading provider of heat treatment and specialist thermal processing services worldwide. Heat treatment encompasses a variety of techniques and specialist engineering processes which improve the properties of metals and alloys and extend the life of components and is a vital part of any manufacturing process. Bodycote is uniquely placed via our global network and the experience and knowledge of our people to offer high quality, reliable and cost-effective services to manufacturers whatever their size or market sector.